Personalized Ex Vivo Platform for Testing Patient Responsiveness to Therapeutics for Inflammatory Disorders
A novel and innovative organoid co-culture system for studying immune-mediated tissue damage and testing patient responses to therapies for inflammatory disorders.
Apoptosis Inhibitor 5 (API5)-based Therapeutic for the Treatment of Inflammatory Bowel Diseases
A novel disease-modifying treatment of inflammatory bowel diseases that doesn't compromise the patient immune system.
Topical Inhibition of HIF-1a as a Novel Therapeutic Strategy for Inflammatory Skin Diseases
An effective, differentiated, and targeted therapeutic strategy for the treatment of inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa.
Epitranscriptomic Modulation of Type I IFN Pathway to Treat Cancer and Autoimmune, Inflammatory, and Infectious Diseases
An innovative and targeted approache to treat cancer and autoimmune, inflammatory, and infectious diseases
Novel Probiotic Compositions for Improving Metabolism and Immunity
Innovative probiotic formulation to prevent and treat metabolic and immune disorders
Small Molecule Inhibitors of SPNS2 for the Treatment of Chronic Inflammatory Diseases
Novel Lumican-Binding Peptides Acting on the Toll-Like Receptor Pathway in Inflammation and Related Conditions
Novel peptides for treating conditions or diseases resulting from dysregulation in the immune system, such as septic shock, wound healing and autoimmune diseases.
Succinate Receptor 1 (SUCNR1) Antagonists to Treat Neuroinflammation
A promising therapeutic target for the prevention and/or treatment of neurodegenerative diseases.